Association of the expression level of the long non-coding RNA TINCR in peripheral blood with Th1/Th2 balance and prognosis after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma

Tao BAI; Jingli WANG; Xudong HU; Bing XIA; Hailin CHENG; Juan WANG

doi:10.3969/j.issn.1001-5256.2021.01.016

Volume 37 Issue 1

Jan. 2021

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2021 > 37(1): 79-83

PDF( 2128 KB)

Association of the expression level of the long non-coding RNA TINCR in peripheral blood with Th1/Th2 balance and prognosis after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma

DOI: 10.3969/j.issn.1001-5256.2021.01.016

a.
Department of Gastroenterology, Jinyintan Hospital, Wuhan 430023, China
b.
Department of Hepatology, Jinyintan Hospital, Wuhan 430023, China
c.
Department of Infectious Diseases, Jinyintan Hospital, Wuhan 430023, China

Received Date: 2020-04-30
Accepted Date: 2020-08-21
Published Date: 2021-01-20

Abstract

Abstract

Objective To investigate the association of the expression level of the long non-coding RNA (lncRNA) TINCR in peripheral blood with Th1/Th2 balance and prognosis after transcatheter arterial chemoembolization (TACE) in patients with hepatocellular carcinoma (HCC). Methods A retrospective analysis was performed for the clinical data of 85 patients with HCC who were treated with TACE in Jinyintan Hospital from March 2015 to March 2017, and 30 healthy volunteers who underwent physical examination in our hospital were randomly selected as control group. The expression of lncRNA TINCR and Th1/Th2 cytokines in peripheral blood were measured on day 7 after TACE for HCC patients and the control group. The t-test was used for comparison of continuous data, the chi-square test was used for comparison of categorical data, and the Kruskal-Wallis H test was used for comparison of ranked data. A Spearman correlation analysis was used to investigate the correlation of the relative expression of lncRNA TINCR with Th1/Th2 cytokines. The Kaplan-Meier survival curves were used to investigate the influence of the relative expression of lncRNA TINCR on survival, and the log-rank test was used for comparison of survival curves. Results The HCC group had significantly higher relative expression of lncRNA TINCR in peripheral blood than the control group (1.784±0.429 vs 0.926±0.263, t=10.277, P < 0.05). The relative expression of lncRNA TINCR was associated with vascular invasion, tumor size, tumor stage, and serum alpha-fetoprotein (t=3.958, 4.499, 3.361, and 4.949, P < 0.001, P < 0.001, P=0.001, and P < 0.001). Compared with the control group, the HCC group had significantly lower serum levels of interferon-γ (IFNγ)[(13.48±5.20) pg/ml vs (27.49±7.21) pg/ml, t=11.408, P < 0.05] and interleukin-2 (IL-2) [(21.89±6.45) pg/ml vs (32.05±7.89) pg/ml, t=6.986, P < 0.05] and significantly higher serum levels of interleukin-4 (IL-4) [(13.73±3.35) pg/ml vs (9.36±2.73) pg/ml, t=6.426, P < 0.05] and interleukin-10 (IL-10) [(12.75±2.74) pg/ml vs (8.93±2.16) pg/ml, t=6.909, P < 0.05]. In HCC patients, the relative expression of lncRNA TINCR in peripheral blood was negatively correlated with the serum levels of IFNγ and IL-2(r=-3.164 and -3.270, both P < 0.001) and was positively correlated with the serum levels of IL-4 and IL-10 (r=2.963 and 3.044, P=0.007 and P < 0.001). With the relative expression of lncRNA TINCR of ≥1.700 as high expression, there were 47 HCC patients with high expression and 38 HCC patients with low expression. The log-rank test showed that the patients with low expression of lncRNA TINCR had significantly better survival than those with high expression (χ²=4.182, P < 0.05). Conclusion HCC patients have significantly higher expression of lncRNA TINCR in peripheral blood than the healthy population, and the expression of lncRNA TINCR is closely associated with the pathological features and Th1/Th2 immune balance of patients and can thus be used as one of the potential indicators for predicting the survival and prognosis of patients.
- Carcinoma, Hepatocellular,
- Chemoembolization, Therapeutic,
- RNA, Long Noncoding,
- Th1-Th2 Balance,
- Prognosis

FullText(HTML)

References(21)

References

[1]	LI XC, WANG HW, LI CX. Present situation and prospect of comprehensive treatment of hepatocellular carcinoma[J]. Chin J Dig Surg, 2018, 17(5): 433-436. (in Chinese) DOI: 10.3760/cma.j.issn.1673-9752.2018.05.004 李相成, 王宏伟, 李长贤. 肝癌综合治疗的现状与展望[J]. 中华消化外科杂志, 2018, 17(5): 433-436. DOI: 10.3760/cma.j.issn.1673-9752.2018.05.004
[2]	Bureau of Medical Administration, National Health Commission of the People's Republic of China. Guidelines for diagnosis and treatment of primary liver cancer in China (2019 edition)[J]. J Clin Hepatol, 2020, 36(2): 277-292. (in Chinese) DOI: 10.3969/j.issn.1001-5256.2020.02.007 中华人民共和国国家卫生健康委员会医政医管局. 原发性肝癌诊疗规范(2019年版)[J]. 临床肝胆病杂志, 2020, 36(2): 277-292. DOI: 10.3969/j.issn.1001-5256.2020.02.007
[3]	CHEN Z, YAO L, LIU Y, et al. LncTIC1 interacts with β-catenin to drive liver TIC self-renewal and liver tumorigenesis[J]. Cancer Lett, 2018, 430: 88-96. DOI: 10.1016/j.canlet.2018.05.023
[4]	HUANG LN, LENG KM, XU Y, et al. Expressions and roles of long non-coding RNA ROR in tumors[J]. Mod Med J, 2017, 45(12): 1865-1870.(in Chinese) DOI: 10.3969/j.1671-7562.2017.12.041 黄立宁, 冷开明, 徐艺, 等. 长链非编码RNA ROR在肿瘤中的表达和作用[J]. 现代医学, 2017, 45(12): 1865-1870. DOI: 10.3969/j.1671-7562.2017.12.041
[5]	HE T, ZHANG L, KONG Y, et al. Long non-coding RNA CASC15 is upregulated in hepatocellular carcinoma and facilitates hepatocarcinogenesis[J]. Int J Oncol, 2017, 51(6): 1722-1730. DOI: 10.3892/ijo.2017.4175
[6]	CHEN Z, LIU Y, YAO L, et al. The long noncoding RNA lncZic2 drives the self-renewal of liver tumor-initiating cells via the protein kinase C substrates MARCKS and MARCKSL1[J]. J Biol Chem, 2018, 293(21): 7982-7992. DOI: 10.1074/jbc.RA117.001321
[7]	TANG GJ, TIAN Y, WANG JT, et al. Advances in long non-coding RNA in chemotherapeutic resistance of hepatocellular carcinoma[J]. Med J Chin PLA, 2020, 45(5): 547-553. (in Chinese) https://www.cnki.com.cn/Article/CJFDTOTAL-JFJY202005016.htm 唐贵菊, 田塬, 王继婷, 等. 长链非编码RNA在肝癌化疗耐药中的研究进展[J]. 解放军医学杂志, 2020, 45(5): 547-553. https://www.cnki.com.cn/Article/CJFDTOTAL-JFJY202005016.htm
[8]	LIU T, YANG H, FAN W, et al. Mechanisms of MAFG dysregulation in cholestatic liver injury and development of liver cancer[J]. Gastroenterology, 2018, 155(2): 557-571. e14. DOI: 10.1053/j.gastro.2018.04.032
[9]	CAI C, YANG L, TANG Y, et al. Prediction of overall survival in gastric cancer using a nine-lncRNA[J]. DNA Cell Biol, 2019, 38(9): 1005-1012. DOI: 10.1089/dna.2019.4832
[10]	LIU HR, LIU XL, YIN BB, et al. Association between SALL4 and lncRNA in human hepatocellular carcinoma[J]. Chin J Cancer Prev Treat, 2017, 24(21): 1518-1522, 1529.(in Chinese) https://www.cnki.com.cn/Article/CJFDTOTAL-QLZL201721007.htm 刘海荣, 刘晓琳, 殷蓓蓓, 等. 原发性肝细胞肝癌组织SALL4与LncRNA表达相关性研究[J]. 中华肿瘤防治杂志, 2017, 24(21): 1518-1522, 1529. https://www.cnki.com.cn/Article/CJFDTOTAL-QLZL201721007.htm
[11]	WU J, LI JT, WEI HL, et al. Advances in the role of microRNA in the intervention of malignant transformation of precancerous lesions of the liver by regulating the activation of hepatic stellate cells[J]. J Clin Hepatol, 2020, 36(7): 1650-1654. (in Chinese) DOI: 10.3969/j.issn.1001-5256.2020.07.045 吴杰, 李京涛, 魏海梁, 等. microRNA调控肝星状细胞活化干预肝癌癌前病变的研究进展[J]. 临床肝胆病杂志, 2020, 36(7): 1650-1654. DOI: 10.3969/j.issn.1001-5256.2020.07.045
[12]	PANG Y, KARTSONAKI C, TURNBULL I, et al. Diabetes, plasma glucose, and incidence of fatty liver, cirrhosis, and liver cancer: A prospective study of 0.5 million people[J]. Hepatology, 2018, 68(4): 1308-1318. DOI: 10.1002/hep.30083
[13]	ZHAI JJ, DU XR, LI CX. Effect of lncRNA HOTAIR on the radiosensitivity of HCCLM3 cells[J]. Natl Med J China, 2020, 100(18): 1419-1425.(in Chinese) DOI: 10.3760/cma.j.cn112137-20190928-02130 翟金俊, 杜贤荣, 李彩霞. lncRNA HOTAIR对肝癌细胞HCCLM3放射敏感性的影响[J]. 中华医学杂志, 2020, 100(18): 1419-1425. DOI: 10.3760/cma.j.cn112137-20190928-02130
[14]	FANG T, LV H, LV G, et al. Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer[J]. Nat Commun, 2018, 9(1): 191. DOI: 10.1038/s41467-017-02583-0
[15]	MALKI A, EL-SHARKAWY A, EL SYAED M, et al. Antitumor activities of the novel isosteviol derivative 10C against liver cancer[J]. Anticancer Res, 2017, 37(4): 1591-1601. DOI: 10.21873/anticanres.11489
[16]	YANG PJ, LI X, DOU KF. Research progress of long non coding RNA in transplantation immunity[J]. Ogran Transplantation, 2018, 9(2): 91-96. (in Chinese) https://www.cnki.com.cn/Article/CJFDTOTAL-QGYZ201802001.htm 杨佩军, 李霄, 窦科峰. 长链非编码RNA在移植免疫中的研究进展[J]. 器官移植, 2018, 9(2): 91-96. https://www.cnki.com.cn/Article/CJFDTOTAL-QGYZ201802001.htm
[17]	CHEN SS, CHEN X, JIANG QY, et al. Expression and prognostic significance of long non-coding RNA CCAT1 in hepatocellular carcinoma[J]. J Med Res, 2018, 47(9): 86-89.(in Chinese) https://www.cnki.com.cn/Article/CJFDTOTAL-YXYZ201809022.htm 陈思思, 陈霞, 蒋琼英, 等. 长链非编码RNA CCAT1在肝细胞肝癌中的表达及预后意义[J]. 医学研究杂志, 2018, 47(9): 86-89. https://www.cnki.com.cn/Article/CJFDTOTAL-YXYZ201809022.htm
[18]	ZHANG S, ZHU J, WU XB, et al. Expressions of LncRNA TINCR and ANRIL in liver cancer tissues and their relationships with the prognosis of the patients[J]. J Trop Med, 2019, 19(1): 55-59. (in Chinese) https://www.cnki.com.cn/Article/CJFDTOTAL-RDYZ201901014.htm 张帅, 朱佳, 吴相柏, 等. 肝癌组织LncRNA TINCR和ANRIL表达水平及其与患者预后的关系[J]. 热带医学杂志, 2019, 19(1): 55-59. https://www.cnki.com.cn/Article/CJFDTOTAL-RDYZ201901014.htm
[19]	ZHOU W, ZHANG S, LI J, et al. lncRNA TINCR participates in ALA-PDT-induced apoptosis and autophagy in cutaneous squamous cell carcinoma[J]. J Cell Biochem, 2019, 120(8): 13893-13902. DOI: 10.1002/jcb.28662
[20]	HOU A, ZHANG Y, ZHENG Y, et al. LncRNA terminal differentiation-induced ncRNA (TINCR) sponges miR-302 to upregulate cyclin D1 in cervical squamous cell carcinoma (CSCC)[J]. Hum Cell, 2019, 32(4): 515-521. DOI: 10.1007/s13577-019-00268-y
[21]	HE X, LI L, FANG Y, et al. In vivo imaging of leucine aminopeptidase activity in drug-induced liver injury and liver cancer via a near-infrared fluorescent probe[J]. Chem Sci, 2017, 8(5): 3479-3483. DOI: 10.1039/C6SC05712H

Relative Articles

[1]	Zhanhu BI, Linxu WANG, Haifeng HU, Hong DU, Yidi DING, Xiaofei YANG, Jiayi ZHAN, Fei HU, Denghui YU, Hongkai XU, Jianqi LIAN. Clinical features and early warning indicators of patients with acute-on-chronic liver failure and bacterial infection[J]. Journal of Clinical Hepatology, 2024, 40(4): 760-766. doi: 10.12449/JCH240419
[2]	Fangfang QIAO, Changyu SUN, Jiaqian HE, Shaoyu DONG, Jianying ZHANG. Value of international normalized ratio-to-platelet ratio in the diagnosis of liver fibrosis in patients with primary biliary cholangitis[J]. Journal of Clinical Hepatology, 2022, 38(3): 553-557. doi: 10.3969/j.issn.1001-5256.2022.03.012
[3]	Xiaoyan LIU, Jinhua HU, Chen LI, Jing CHEN, Jingjing TONG, Chongdan GUAN, Yuhui PENG, Peng NING, Lilong YAN, Haibin SU. Clinical features of patients with acute-on-chronic liver failure and bacterial infection and influencing factors for prognosis[J]. Journal of Clinical Hepatology, 2021, 37(9): 2148-2152. doi: 10.3969/j.issn.1001-5256.2021.09.028
[4]	Wang ZhiXin, Gou Ping, Yu WenHao, Ren Li, Yang DanCaiRang, Wang HaiJiu, Fan HaiNing. Measurement and bioinformatics analysis of exosomes microRNAs in bile of hepatic alveolar echinococcosis patients with biliary tract invasion[J]. Journal of Clinical Hepatology, 2020, 36(9): 2045-2049. doi: 10.3969/j.issn.1001-5256.2020.09.027
[5]	Wang RongFeng, Lu: Yi, Zhang XiaoGang. Advances in the diagnosis and treatment of severe acute cholangitis[J]. Journal of Clinical Hepatology, 2019, 35(12): 2622-2626. doi: 10.3969/j.issn.1001-5256.2019.12.002
[6]	Li Chen, Su HaiBin, Liu XiaoYan, Xu Xiang, Li Hui, Peng YuHui, Yan LiLong. Clinical outcome of patients with acute-on-chronic liver failure and bacterial infection after 72 hours of anti-infective therapy[J]. Journal of Clinical Hepatology, 2019, 35(1): 147-152. doi: 10.3969/j.issn.1001-5256.2019.01.028
[7]	Zhao YouYou, Zhang Duan, Yin Xin, Wen XiaoYu, Gao PuJun. Glucocorticoid treatment of intrahepatic cholestasis caused by infectious cholangitis: A case report[J]. Journal of Clinical Hepatology, 2019, 35(2): 386-387. doi: 10.3969/j.issn.1001-5256.2019.02.031
[8]	Sun ChunYan, Ma Xiong. An excerpt of EASL Clinical Practice Guidelines: the diagnosis and management of patients with primary biliary cholangitis(2017)[J]. Journal of Clinical Hepatology, 2017, 33(10): 1888-1894. doi: 10.3969/j.issn.1001-5256.2017.10.008
[9]	Zhao Jian, Tian Hao, Yao DingKang. Research advances in primary biliary cholangitis complicated by osteoporosis[J]. Journal of Clinical Hepatology, 2017, 33(11): 2226-2229. doi: 10.3969/j.issn.1001-5256.2017.11.039
[10]	Dong KaiHui, Wang Yao, Fang YiNa, Kui YiWen, Wen XiaoYu, Jin QingLong. Renal tubular acidosis in primary biliary cholangitis:a case report[J]. Journal of Clinical Hepatology, 2017, 33(11): 2190-2191. doi: 10.3969/j.issn.1001-5256.2017.11.029
[11]	Han Tao. Acute-on-chronic liver failure due to bacterial infection in liver cirrhosis: causes and management[J]. Journal of Clinical Hepatology, 2015, 31(9): 1415-1417. doi: 10.3969/j.issn.1001-5256.2015.09.012
[12]	Cai JunJun, Han Tao. Bacterial infections in cirrhosis: a summary of position statement based on the EASL Special Conference 2013[J]. Journal of Clinical Hepatology, 2014, 30(7): 588-591. doi: 10.3969/j.issn.1001-5256.2014.07.003
[13]	Fan HeBin, Li Zhi, Li Jian, Chen AnShen, Xu LiTong, Zhou Hao, Tian ZhanFei, Ma XiaoJu, Sun Jie, Yan FuMing. The clinical features and prognosis of sepsis-associated cholestasis in patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2013, 29(3): 208-210.
[14]	Liu JingHua, Wang Min, Zou Yu. Metagenomic analysis reveals gallstone types associated with gut microbiome community composition[J]. Journal of Clinical Hepatology, 2012, 28(7): 522-524+527.
[15]	Lu LunGen. Mechanism of bile secretion, excretion, regulation and cholestasis[J]. Journal of Clinical Hepatology, 2011, 27(6): 570-571+580.
[16]	Bao ZhengHua, Han Zhen. Progress in the treatment of primary sclerosing cholangitis[J]. Journal of Clinical Hepatology, 2011, 27(6): 663-666.
[17]	Shu HuiJun, Zhu Feng. Diagnosis and treatment of primary sclerosing cholangitis[J]. Journal of Clinical Hepatology, 2011, 27(6): 591-594.
[18]	Liu SuLi, Xing GuoZhang, Zhang YueHan, Wang DingXin, Zhang JianSheng. The valuable tumormarkers of CEA and CA19-9 in the bile for diagnosis of cholangiocarcinoma and carcinoma of ampulla[J]. Journal of Clinical Hepatology, 2009, 25(2): 125-126.

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Figures(1) / Tables(2)

Get Citation

PDF

XML

Article Metrics

Article views (738) PDF downloads(62)

Association of the expression level of the long non-coding RNA TINCR in peripheral blood with Th1/Th2 balance and prognosis after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma

DOI: 10.3969/j.issn.1001-5256.2021.01.016

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Association of the expression level of the long non-coding RNA TINCR in peripheral blood with Th1/Th2 balance and prognosis after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma

DOI: 10.3969/j.issn.1001-5256.2021.01.016

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content